Skip to main content
SpringerLink
Log in

Fluoroquinolones in Urinary Tract Infections

Proper and Improper Use

  • Section 2: The Appropriate Use of Quinolones
  • Short Communication
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Naber KG, Wittenberger R. In-vitro-Aktivität von Gyrase-Hemmern gegenüber Erregern von komplizierten Harnwegsinfektionen. Fortschritte der Antimikrobiellen und Antineoplastischen Chemotherapie (FAC) 1987; 6–10: 1801–9

    Google Scholar 

  2. Naber KG, Witte W, Bauernfeind A, et al. Resistenzentwicklung gegenüber Fluorochinolonen. Untersuchungen mit Erregern von Patienten mit komplizierten Harnwegsinfektionen. Chemotherapie Journal 1993; 2: 106–11.

    Google Scholar 

  3. Naber KG. Uncomplicated urinary tract infections — is single-dose therapy effective? Int J Antimicrob Agents 1994; 4 Suppl. 2: 39–45

    Article  Google Scholar 

  4. Gellermann HJ, Grote J, Peters-Haertel W, et al. Kurzzeit-Therapie von unkomplizierten Harnwegsinfektionen der Frau mit Ciprofloxacin. Med Welt 1988; 39: 1586–91.

    Google Scholar 

  5. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 753–6.

    Article  PubMed  CAS  Google Scholar 

  6. Smellie JM, Ransley PG, Normand ICS, et al. Development of new renal scars: a collaborative study. BMJ 1985; 290: 1957–60.

    Article  PubMed  CAS  Google Scholar 

  7. Naber KG, Bauernfeind A, Dietlein G, et al. Urinary pathogens and bacterial sensitivity in hospitalized urological patients based upon clinical aspects. Scand J Urol Nephrol 1987; Suppl. 104: 47–57

    CAS  Google Scholar 

  8. Naber KG, Witte W, Bauernfeind A, et al. Clinical significance and spread of fluoroquinolone resistant uropathogens in hospitalised urological patients. Infection 1994; 22 Suppl. 2: 122–7.

    Article  Google Scholar 

  9. Naber KG. Use of quinolones in urinary tract infections and prostatitis. Rev Infect Dis 1989; 11 Suppl. 5: S1321–37.

    Article  PubMed  Google Scholar 

  10. Frankenschmidt A, Bischoff W, Naber KG, et al. Fleroxacin in the oral treatment of complicated urinary tract infections [poster no. 3144]. 19th International Congress of Chemotherapy: 1995 July 16–21: Montréal, Québec, Canada

  11. Cross AS, Opal S, Kopecko D. Progressive increase in antibiotic resistance of Gram-negative bacterial isolates. Walter Reed Hospital, 1976 to 1980: specific analysis of gentamicin, tobramycin, and amikacin resistance. Arch Intern Med 1983; 143: 2075–80.

    Article  PubMed  CAS  Google Scholar 

  12. Holder IA. Gentamicin resistant Pseudomonas aeruginosa in a burn unit. J Antimicrob Chemother 1986; 2: 309–11.

    Article  Google Scholar 

  13. Wagenlehner FME. Auftreten von Fluorochinolon-resistenten Erregern bei komplizierten Harnwegsinfektionen in Korrelation zu klinischen Aspekten, 1996; Inaugural-Dissertation: Medical School of Technical University of Munich, Germany. In press

  14. Sauerwein D, Bauernfeind A. Klinische Erfahrungen bei Behandlung von Harnwegsinfektionen bei Querschnittgelähmten mit Norfloxacin. Fortschritte der Antimikrobiellen und Antineoplastischen Chemotherapie (FAC) 1984; 3–5: 759–64

    Google Scholar 

  15. Kumon H, Ono N, Iida M, et al. Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm. Antimicrob Agents Chemother 1995; 39: 1038–44.

    Article  PubMed  CAS  Google Scholar 

  16. Goto T, Nakame Y, Nishida M. In vitro and in vivo bactericidal effects of antibiotics on Pseudomonas aeruginosa biofilm in the urine [abstract no. 0671]. 19th International Congress of Chemotherapy: 1995 July 16–21: Montréal, Québec, Canada

  17. Kumamoto Y, Nishimura M, Sano M, et al. Clinical study of combination therapy with clarithromycin and ciprofloxacin for complicated urinary tract infection as biofilm diseases [abstract no. 0317]. 19th International Congress of Chemotherapy 1995: July 16–21: Montréal, Québec, Canada

  18. Peeling RW, Ronald AR. Use of quinolones in sexually transmitted diseases. In: Hooper DC, Wolfson JS, editors. Quinolone antimicrobial agents. 2nd ed. 1993: American Society for Microbiology, Washington DC, USA: 299–327

    Google Scholar 

  19. Grandsen WR, Warren CA, Phillips I, et al. Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacin. Lancet 1990; 335: 51.

    Google Scholar 

  20. Oriel JD. Male genital Chlamydia trachomatis infections. J Infect 1992; 25 Suppl. 1:35–7

    Article  PubMed  Google Scholar 

  21. Ridgway GL. Advances in the antimicrobial therapy of Chlamydial genital infections. J Infect 1992; 25 Suppl. 1:51–9

    Article  PubMed  Google Scholar 

  22. Fong IW, Linton W, Simbul M, et al. Treatment of nongonococcal urethritis with ciprofloxacin. Am J Med 1987; 82 Suppl. 4a: 311–6.

    PubMed  CAS  Google Scholar 

  23. Hooton TM, Rogers E, Medina TG, et al. Ciprofloxacin compared with doxycycline for nongonococcal urethritis. JAMA 1990; 264: 1418–21.

    Article  PubMed  CAS  Google Scholar 

  24. Nilsen A, Halsos A, Johansen A, et al. A double blind study of single dose azithromycin and doxycycline in the treatment of Chlamydial urethritis in males. Genitourin Med 1992; 68: 325–7.

    PubMed  CAS  Google Scholar 

  25. Meares Jr EM. Prostatitis syndromes: new perspectives about old woes. J Urol 1980; 123: 141–7.

    PubMed  Google Scholar 

  26. Stamey TA, Meares Jr EM, Winningham DG. Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid. J Urol 1970; 103: 187–94.

    PubMed  CAS  Google Scholar 

  27. Hanus PM, Danzinger LH. Treatment of chronic bacterial prostatitis. Clin Pharmacy 1984; 3: 49–55.

    CAS  Google Scholar 

  28. Naber KG. Role of quinolones in treatment of chronic bacterial prostatitis. In: Hooper DC, Wolfson JS, editors. Quinolone antimicrobial agents. 2nd ed. 1993: American Society for Microbiology, Washington DC, USA: 285–97

    Google Scholar 

  29. Naber KG, Giamarellou H. Proposed study design in prostatitis. Infection 1994; 22 Suppl. 1: 59–60.

    Article  Google Scholar 

  30. van Poppel H, Willimen P, Wegge M, et al. Antibiotic cover of transurethral maneuvers with ciprofloxacin and susceptibility behavior of pathogens in patients with neurogenic bladder. Urol Int 1990; 45: 342–5.

    Article  PubMed  Google Scholar 

  31. Hofer DR, Schaeffer AJ. Use of antimicrobials for patients undergoing prostatectomy. Urol Clin North Am 1990; 17: 595–600.

    PubMed  CAS  Google Scholar 

  32. Murphy DM, Falkiner FR, Carr M, et al. Septicaemia after transurethral prostatectomy. Urology 1983; 22: 133–5.

    Article  PubMed  CAS  Google Scholar 

  33. Grabe M. Antimicrobial agents in transurethral prostatic resection. J Urol 1987; 138: 245–52.

    PubMed  CAS  Google Scholar 

  34. Larsen E, Gasser TC, Madsen PO. Antimicrobial prophylaxis in urologic surgery. Urol Clin North Am 1986; 13: 591–604.

    PubMed  CAS  Google Scholar 

  35. Finkelstein LH, Arsht DB, Manfrey SJ, et al. Ceftriaxone in the prevention of postoperative infection in patients undergoing transurethral prostatectomy. Am J Surg 1984; 148 Suppl. 4A: 19–21.

    PubMed  CAS  Google Scholar 

  36. Viitanen J, Talja M, Jussila E, et al. Randomized controlled study of chemoprophylaxis in transurethral prostatectomy. J Urol 1993; 150: 1715–7.

    PubMed  CAS  Google Scholar 

  37. Hargreave TB, Botto H, Rikken GHJM, et al. European collaborative study of antibiotic prophylaxis for transurethral resection of the prostate. Eur Urol 1993; 23: 437–43.

    PubMed  CAS  Google Scholar 

  38. Raz R, Ahnog D, Elhanan G, et al. The use of ceftriaxone in the prevention of urinary tract infection in patients undergoing transurethral resection of the prostate (TUR-P). Infection 1994; 22: 347–9.

    Article  PubMed  CAS  Google Scholar 

  39. Shearman CP, Silverman SH, Johnson M, et al. Single dose, oral antibiotic cover for transurethral prostatectomy. Br J Urol 1988; 62: 434–8.

    Article  PubMed  CAS  Google Scholar 

  40. Gasser TC. Transurethral resection of the prostate. Western Pacific Congress on Chemotherapy and Infectious Diseases [abstract no. 31]. 7th European Congress of Clinical Microbiology and Infectious Diseases: 1995 Mar 26–30: Vienna, Austria

Download references

Author information

Authors and Affiliations

  1. Urology Clinic, Elisabeth Hospital, Teaching Hospital of the University of Munich Medical School, Schulgasse 20, D-94315, Straubing, Germany

    Kurt G. Naher

Authors
  1. Kurt G. Naher
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naher, K.G. Fluoroquinolones in Urinary Tract Infections. Drugs 52 (Suppl 2), 27–33 (1996). https://doi.org/10.2165/00003495-199600522-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199600522-00006

Keywords

Search

Navigation